Andy I. M. Hoepelman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andy I. M. Hoepelman has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Suzanne E. Geerlings
Vrije Universiteit Medical Center
3 shared publications- Myriam M. Lipovsky
Department of Medicine, Division of Infectious Diseases and AIDS, Room F.02.126, University Medical Center, P.O. Box 85500, 3508 GA Utrecht, The Netherlands
2 shared publications - Ronald P. Stolk
University of Groningen
2 shared publications A F Verheul
University Hospital Utrecht, The Netherlands
1 shared publicationA M Walenkamp
University Hospital Utrecht, The Netherlands
1 shared publicationA. Buiting
<!--label omitted: 5-->Department of Microbiology,5 St. Elisabeth Hospital, Tilburg
1 shared publication
Latest Publications
- 1 April 2010
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 14 (4) , e304-e307
Escherichia coli bacteriuria in female adults is associated with the development of hypertension
- 1 April 2010
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 14 (4) , e304-e307
Escherichia coli bacteriuria in female adults is associated with the development of hypertension
- 18 August 2004
- Published by Wiley in Diabetic Medicine
- Vol. 21 (9) , 1032-1034
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria
AIM: To investigate whether diabetes mellitus is a risk factor for resistance in Escherichia coli isolated from patients with bacteriuria. METHODS: Data were obtained from a multicentre study. A clean-voided midstream urine culture was collected from 636 women with diabetes, who were between 18 and 75-years-old, attended an out-patient department and had no symptoms of a urinary tract infection. The resistance of E. coli was determined for different antimicrobials. The results were compared with resistance data from routine isolates of E. coli, obtained from women in the same age category, time period and location. RESULTS: A total of 135 E. coli were isolated from women with diabetes mellitus (mean age 57 +/- 14 years) and compared with 5907 routine isolates of E. coli obtained from female patients visiting an out-patient department (mean age 52 +/- 17 years). The resistance rates of E. coli isolated from diabetic patients and the routine isolates of E. coli to trimethoprim-sulfamethoxazole were 19% and 23%, respectively, to amoxicillin 16% and 32%, to nitrofurantoin 1% and 3%, to ciprofloxacin 0% and 4%, to ofloxacin 0% and 5%, and to norfloxacin 1% and 4%. CONCLUSION: The resistance of uropathogenic E. coli in non-hospitalized women with diabetes mellitus is not higher than that seen in routine isolates of E. coli. This suggests that diabetes in itself is not a risk factor for resistanc
- 18 August 2004
- Published by Wiley in Diabetic Medicine
- Vol. 21 (9) , 1032-1034
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria
AIM: To investigate whether diabetes mellitus is a risk factor for resistance in Escherichia coli isolated from patients with bacteriuria. METHODS: Data were obtained from a multicentre study. A clean-voided midstream urine culture was collected from 636 women with diabetes, who were between 18 and 75-years-old, attended an out-patient department and had no symptoms of a urinary tract infection. The resistance of E. coli was determined for different antimicrobials. The results were compared with resistance data from routine isolates of E. coli, obtained from women in the same age category, time period and location. RESULTS: A total of 135 E. coli were isolated from women with diabetes mellitus (mean age 57 +/- 14 years) and compared with 5907 routine isolates of E. coli obtained from female patients visiting an out-patient department (mean age 52 +/- 17 years). The resistance rates of E. coli isolated from diabetic patients and the routine isolates of E. coli to trimethoprim-sulfamethoxazole were 19% and 23%, respectively, to amoxicillin 16% and 32%, to nitrofurantoin 1% and 3%, to ciprofloxacin 0% and 4%, to ofloxacin 0% and 5%, and to norfloxacin 1% and 4%. CONCLUSION: The resistance of uropathogenic E. coli in non-hospitalized women with diabetes mellitus is not higher than that seen in routine isolates of E. coli. This suggests that diabetes in itself is not a risk factor for resistanc
- 1 October 2003
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 22, 35-43
Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus
- 1 October 2003
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 22, 35-43
Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus
- 1 June 2002
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 21 (6) , 427-431
Double-Blind, Placebo-Controlled Study Comparing the Effect of Azithromycin with Clarithromycin on Oropharyngeal and Bowel Microflora in Volunteers
The purpose of this double-blind study was to assess the effect of azithromycin and clarithromycin on oral and fecal microflora. Bacterial species from fecal samples and throat washes from healthy volunteers were identified and quantified before, during and after receipt of either placebo (n=6), azithromycin (500 mg once daily for 3 days; n=6) or clarithromycin (500 mg twice daily for 7 days; n=6). In both antibiotic groups, the changes in oropharyngeal aerobic microflora following antibiotic administration were minor. Antibiotics neither changed the bacterial load of Streptococcus spp. compared with placebo, nor did macrolide-resistant streptococci emerge. In the fecal aerobic microflora, the number of organisms of the family Enterobacteriaceae decreased slightly after antibiotic administration in both the clarithromycin and the azithromycin groups, but levels normalized by day 21 after therapy. No colonization with nonfermenters or Clostridium difficile was seen, and the total number of anaerobic bacteria was not affected in any study group. In conclusion, there were no significant differences between azithromycin and clarithromycin in their effect on human oropharyngeal and intestinal microflora, nor was the use of these antibiotics associated with colonization by resistant, gram-positive organisms or overgrowth of opportunistic microorganisms.
- 1 June 2002
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 21 (6) , 427-431
Double-Blind, Placebo-Controlled Study Comparing the Effect of Azithromycin with Clarithromycin on Oropharyngeal and Bowel Microflora in Volunteers
The purpose of this double-blind study was to assess the effect of azithromycin and clarithromycin on oral and fecal microflora. Bacterial species from fecal samples and throat washes from healthy volunteers were identified and quantified before, during and after receipt of either placebo (n=6), azithromycin (500 mg once daily for 3 days; n=6) or clarithromycin (500 mg twice daily for 7 days; n=6). In both antibiotic groups, the changes in oropharyngeal aerobic microflora following antibiotic administration were minor. Antibiotics neither changed the bacterial load of Streptococcus spp. compared with placebo, nor did macrolide-resistant streptococci emerge. In the fecal aerobic microflora, the number of organisms of the family Enterobacteriaceae decreased slightly after antibiotic administration in both the clarithromycin and the azithromycin groups, but levels normalized by day 21 after therapy. No colonization with nonfermenters or Clostridium difficile was seen, and the total number of anaerobic bacteria was not affected in any study group. In conclusion, there were no significant differences between azithromycin and clarithromycin in their effect on human oropharyngeal and intestinal microflora, nor was the use of these antibiotics associated with colonization by resistant, gram-positive organisms or overgrowth of opportunistic microorganisms.
- 1 January 2002
- Published by Springer Nature in Drugs
- Vol. 62 (13) , 1859-1868
Management of bacterial urinary tract infections in adult patients with diabetes mellitus.
- 1 January 2002
- Published by Springer Nature in Drugs
- Vol. 62 (13) , 1859-1868
Management of bacterial urinary tract infections in adult patients with diabetes mellitus.
- 22 September 2001
- Vol. 145 (38) , 1860-2
[Candidate vaccine against urinary tract infections].
Urinary tract infections (UTIs) are an important medical problem for women. The most common uropathogen is Escherichia coli. The adherence of E. coli to the uroepithelium is mediated by the FimH adhesin, a minor component of type-1 fimbriae. This is the initial step in the pathogenesis of UTIs. Recently, a candidate vaccine has been developed, based on this FimH adhesin. In animal studies and in a phase 1 study, this vaccine has proven to be both immunogenic and safe. In this era of increasing resistance to antibiotics, such a method of prevention is of high importance.
- 22 September 2001
- Vol. 145 (38) , 1860-2
[Candidate vaccine against urinary tract infections].
Urinary tract infections (UTIs) are an important medical problem for women. The most common uropathogen is Escherichia coli. The adherence of E. coli to the uroepithelium is mediated by the FimH adhesin, a minor component of type-1 fimbriae. This is the initial step in the pathogenesis of UTIs. Recently, a candidate vaccine has been developed, based on this FimH adhesin. In animal studies and in a phase 1 study, this vaccine has proven to be both immunogenic and safe. In this era of increasing resistance to antibiotics, such a method of prevention is of high importance.
- Open Access
- 11 June 2001
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (11) , 1421-1427
Consequences of Asymptomatic Bacteriuria in Women With Diabetes Mellitus
WOMEN with diabetes mellitus (DM) have asymptomatic bacteriuria (ASB) more often than women without DM.1-3 In a large multicenter study we recently reported a prevalence of ASB of 26% in women with DM and of 6% in women without DM.4 Preliminary findings, based on a small patient sample of Harding et al5 showed that women with DM and ASB had a much higher chance to develop pyelonephritis (and not cystitis) than those without ASB during a 3-year follow-up period. In a small prospective study of 58 women without DM but with ASB (1-year follow-up), 18 women (31%) developed a symptomatic urinary tract infection (UTI).6 In other studies of patients without DM,7 it was suggested that ASB can lead to recurrent UTIs8-10 and progressive renal impairment.11,12 It is unknown, however, whether ASB leads to symptomatic UTI and/or a decline in renal function in patients with DM.2,3 Since DM already is a risk factor for the development of renal function disturbances, the question arises whether the presence of ASB in patients with DM leads to a faster decline in renal function.
- 11 June 2001
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (11) , 1421-1427
Open AccessConsequences of Asymptomatic Bacteriuria in Women With Diabetes Mellitus
WOMEN with diabetes mellitus (DM) have asymptomatic bacteriuria (ASB) more often than women without DM.1-3 In a large multicenter study we recently reported a prevalence of ASB of 26% in women with DM and of 6% in women without DM.4 Preliminary findings, based on a small patient sample of Harding et al5 showed that women with DM and ASB had a much higher chance to develop pyelonephritis (and not cystitis) than those without ASB during a 3-year follow-up period. In a small prospective study of 58 women without DM but with ASB (1-year follow-up), 18 women (31%) developed a symptomatic urinary tract infection (UTI).6 In other studies of patients without DM,7 it was suggested that ASB can lead to recurrent UTIs8-10 and progressive renal impairment.11,12 It is unknown, however, whether ASB leads to symptomatic UTI and/or a decline in renal function in patients with DM.2,3 Since DM already is a risk factor for the development of renal function disturbances, the question arises whether the presence of ASB in patients with DM leads to a faster decline in renal function.
- 1 January 2001
- Published by Elsevier in The Netherlands Journal of Medicine
- Vol. 58 (1) , 1-2
The Journal Volumes 54 and 55
- 1 January 2001
- Published by Elsevier in The Netherlands Journal of Medicine
- Vol. 58 (1) , 1-2
The Journal Volumes 54 and 55
- 1 December 2000
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 19 (12) , 971-973
A case of disseminated infection with Pichia ohmeri.
- 1 December 2000
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 19 (12) , 971-973
A case of disseminated infection with Pichia ohmeri.
- Open Access
- 1 September 2000
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (3) , e3-e4
Is a Second Urine Specimen Necessary for the Diagnosis of Asymptomatic Bacteriuria?
By use of pulse-field gel electrophoresis, we evaluated the molecular identity of 32 Escherichia coli isolates obtained in 2 consecutive urine cultures from 16 patients as part of a large study of asymptomatic bacteriuria in dia-betic women and found different E. coli isolates in 7 of 16 patients, meaning that nearly half (44%) of the patients who had been previously classified as having asymptomatic bacteriuria were reinfected with a different strain.
- 1 September 2000
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (3) , e3-e4
Open AccessIs a Second Urine Specimen Necessary for the Diagnosis of Asymptomatic Bacteriuria?
By use of pulse-field gel electrophoresis, we evaluated the molecular identity of 32 Escherichia coli isolates obtained in 2 consecutive urine cultures from 16 patients as part of a large study of asymptomatic bacteriuria in dia-betic women and found different E. coli isolates in 7 of 16 patients, meaning that nearly half (44%) of the patients who had been previously classified as having asymptomatic bacteriuria were reinfected with a different strain.